contact@king-theme.com   +1 123-456-7890

    Former German firm bringing more biotech business to San Antonio

    San Antonio’s successful recruitment of Cytocentrics more than a year ago has led to another economic win that could further enhance the city’s role in the global bioscience arena. The company, which recently changed its name to CytoBioScience Inc., has acquired a Birmingham, Alabama-based biotech firm called Soluble Therapeutics that will look to establish roots here over the next 12 months. CytoBioScience officials believe the “multimillion-dollar purchase” could draw more companies and talent to the Alamo City. At a minimum, ...
    Read More
    / / Press Releases

    Soluble Therapeutics Acquired by CytoBioscience

    SAN ANTONIO--(BUSINESS WIRE)--CytoBioscience, Inc. has purchased Birmingham, Alabama-based Soluble Therapeutics and will move the company’s operations to its San Antonio location. The deal closed November 1, according to James Garvin, Chief Executive Officer of CytoBioscience. Details of the multi-million dollar purchase price were not disclosed. “The Soluble Therapeutics team has created a business offering that aligns very well with our technology and work to positively impact the efforts of drug development enterprises and researchers across the globe,” he said. “This ...
    Read More
    / / Press Releases

    Soluble Therapeutics Closes on Second Investment Round

    by John McCarter, MS Birmingham, AL- December 2013 - Soluble Therapeutics, Inc. a Birmingham, Alabama–based CRO and product development company specializing in formulation optimization for protein-based Bioscience, announces that it has secured a second round of investment to support the expansion of its formulation development business. This expansion is necessary to meet continued demand for the company’s large molecule formulation service, as well as to accommodate two new research collaborations, one with a global Pharmaceutical Contract Manufacturing Organization (CMO) and ...
    Read More
    / / Press Releases

    Soluble Therapeutics to Launch HSC™ Technology at BioProcess International Conference

    by John McCarter, MS Birmingham-based Soluble Therapeutics, Inc, today announced the official launch of its high-throughput second viral coefficient determination system, HSC™ Technology, at the IBC BioProcess International Conference in Providence, RIOctober 8-12. HSC™ Technology was developed by Dr. Bill Wilson, former Chairman, Chemistry Department at Mississippi State University, and former NASA astronaut, Dr. Larry DeLucas, Director of the Center for Biophysical Sciences & Engineering at the University of Alabama Birmingham. Doctors Wilson and DeLucas have collaborated for the last ...
    Read More
    / / Press Releases

    Soluble Therapeutics, Inc. Awarded ~$1MM NIH Grant for Continued Development of the HSC™ Technology for Protein Formulation

    by John McCarter, MS Birmingham, AL – 1 June 2012 - Soluble Therapeutics, Inc. a Birmingham, Alabama–based CRO specializing in formulation optimization for protein-based therapeutics announces a Phase II award of approximately $1MM from the NIH Small Business Technology Transfer Program (STTR). After closing a $1MM round of venture funding in the summer of 2011, this new infusion of capital will allow Soluble Therapeutics to accelerate the development and commercialization of the HSCTMTechnology for protein formulation – a technology that ...
    Read More
    / / Press Releases

    Soluble Therapeutics, Inc. closes a $1MM Round of VC Funding led by The Birmingham Technology Fund, Greer Capital, and Targeted Technology Fund

    by John McCarter, MS Birmingham, AL – 11 July 2011 - Soluble Therapeutics, Inc. a Birmingham, Alabama–based CRO specializing in formulation optimization for protein-based therapeutics announces the closing of a $1MM investment that includes funds from The Birmingham Technology Fund, Greer Capital, and Targeted Technology Fund. This investment represents confidence from a group that has a strong track record of investing in companies with solid growth histories and clear paths to profitability focused on serving the needs of the pre-clinical ...
    Read More
    / / Press Releases

    Soluble Therapeutics cuts costs and speeds protein research with the HSC™ Technology

    by John McCarter, MS Birmingham, AL – 30 June 2010 - Soluble Therapeutics, LLC officially launches its commercial operations. The Birmingham-based Soluble Therapeutics is the manufacturer and service provider of a new technology for the rapid formulation of protein based drugs. The HSC™ Technology enables researchers to formulate protein-based products using a small amount of their target quickly and relatively inexpensively. The HSC™ Technology will make protein-based drugs, vaccines, and research tools more readily available and available to consumers years ...
    Read More
    / / Press Releases

    SolubleT herapeuticspartners with UAB Biotechnology Program to advance company and program

    by John McCarter, MS Birmingham, AL – 29 June 2011 - At Soluble Therapeutics, the Birmingham-based biotechnology company that provides solutions for proteins, working with The University of Alabama at Birmingham Biotechnology program students and faculty speaks to the company’s commitment to the biotechnology community and the continued progress of the Biotechnology program. It all starts with the students in the new Biotechnology Program at the University. “Our company was founded on technology developed at the Center for Biophysical Sciences ...
    Read More
    / / Press Releases